Navigation Links
Big Pharma's Control over the Russian Government Drug Procurement Tenders Market is Slipping Away
Date:10/15/2014

ST. PETERSBURG, Russia, October 15, 2014 /PRNewswire/ --


Russian pharmaceutical companies are actively  squeezing out foreign therapeutic manufacturers from the government tenders. The рatients' support state program allocates the highest budget for rituximab, a drug used in the treatment of hematological cancers. In 2013, 217 million dollars were appropriated from the federal budget for this drug alone. This year, for the first time, Russian biosimilar drug AcellBia will be supplied under this program.

     (Logo: http://photos.prnewswire.com/prnh/20140514/686712)

For years, all income from sales of rituximab in Russia was booked by the sole producer of the drug, the Swiss company "F. Hoffmann-La Roche AG". In 2014, the Russian drug company BIOCAD entered the Russian market with Accellbia®, biosimilar of Hoffmann-La Roche's MabThera/Rituxan, and as a result the situation has drastically changed.

The Ministry of Health of the Russian Federation will purchase rituximab produced by a Russian company for patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

Currently, a set of documents is under review by regulators at the Ministry of Health of the Russian Federation examining the possibility of granting public contract to BIOCAD, Russian biosimilar rituximab producer, based on the announced results of the tender.

Russian Government's purchase of rituximab in 2014 is approximately 146 million dollars.

About CJSC BIOCAD 

Headquartered in St, Petersburg, Russia, joint-stock company BIOCAD is a leading Russian private biopharmaceutical company, specializing in research, development and manufacture of generic, biosimilar and innovative drugs. BIOACAD works to provide more affordable therapeutic proteins and small-molecule generics to patients who previously had limited access to high-value drugs in the areas of oncology, autoimmune and infectious diseases.

Contact:
Irina Kenyukhova
PR-manager
Phone.: +7(812)380-49-33
FAX: +7(812)380-49-34
e-mail: kenyukhova@biocad.ru


'/>"/>
SOURCE BIOCAD
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. CMS Open Payments (Sunshine Act) Data Now Available on PharmaShine
2. Pharmas Are Leaving Healthcare Professionals Hanging in a Mature Mobile Market, Manhattan Research Study Finds
3. ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform
4. Physicians to Pharmas: Provide Patient Services or Face Irrelevance
5. Virtify Announces Second Webinar on Regulatory Information Management Strategies for Small and Mid-Sized Pharmas
6. Innovation Rolls Out New PharmASSIST Dispenser Model 4 with Medication Self Calibration Capability
7. AstraZeneca Neuroscience partners with ePharmaSolutions to optimize Clinical Trial Management
8. PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
9. ePharmaSolutions Wins Major Award for Life Sciences Industry Innovation
10. In Q1 Public Biopharmas Shift Fundraising into Overdrive
11. Cumberland Pharmaceuticals And PT. SOHO Industri Pharmasi enter Into Exclusive Licensing Agreement For Caldolor In Indonesia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/15/2020)... ... February 14, 2020 , ... February is National Heart ... that cause inflammatory gum disease (e.g., periodontitis) and systemic inflammatory disease (e.g., atherosclerosis). ... tools in the fight against common dental problems such as gum disease, cavities ...
(Date:2/14/2020)... ... February 14, 2020 , ... ... and Commerce beginning fall semester 2020, the first of its kind in this ... in a career in the cannabis industry and will provide students with an ...
(Date:2/14/2020)... ... February 14, 2020 , ... ESO , ... and hospitals, today announced Dr. Daniel Kraft – Faculty Chair for Medicine at ... deliver one of three keynote presentations at Wave 2020 , ESO’s data, ...
Breaking Medicine Technology:
(Date:2/13/2020)... ... 2020 , ... The largest fertility center in the state ... Fredericksburg, Leesburg, and Woodbridge, as well as two locations in the District, is ... as Top Docs for Infertility by Northern Virginia Magazine. , Each of ...
(Date:2/11/2020)... ... February 11, 2020 , ... The wait is finally over. The first wild card for the ... squad has been associating professional sports to a truly special project. , The group was ... entirely of athletes with diabetes. They decided to take on the ambitious mission to show ...
(Date:2/10/2020)... FORT WORTH, Texas (PRWEB) , ... February 10, ... ... Viner has been named vice president in the company’s healthcare division. In this ... expertise, as well as guide the company’s continued healthcare product development. , ...
(Date:2/10/2020)... ... February 10, 2020 , ... ... a medical device company dedicated to assisting healthcare professionals (HCPs) to improve ... the launch of the Solesta® Reimbursement Assistance Program. , Solesta is ...
(Date:2/10/2020)... , ... February 10, 2020 , ... ... who want to learn more about living a better, healthier, and happier life ... approaches and information on a broad variety of topics including intellectual, physical, emotional, ...
Breaking Medicine News(10 mins):